Skip to content
healthcare.dev
Get a free key

NAGLAZYME

NDC 68135-020, galsulfase, solution, from BioMarin Pharmaceutical Inc..

Product NDC
68135-020
Status
Listed
Labeler
BioMarin Pharmaceutical Inc.
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125117
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68135-020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GALSULFASE5 mg/5mL

Pharmacologic classes

Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]; alpha-Glucosidases [CS]

Package NDCNDC-11Package
68135-020-01681350020011 VIAL in 1 CARTON (68135-020-01) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/59341250-deac-ed71-3823-a4f5d64dbd77

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68135-020

Use it

Look up 68135-020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68135-020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68135-020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.